“India is undergoing a structural change as an economy. When India’s GDP per capita rises, which I anticipate will happen exponentially, we cannot just limit ourselves to large cap names because there are only about 200-300 of them.”
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale